Spero Therapeutics
SPRO
#10353
Rank
NZ$79.02 M
Marketcap
NZ$1.36
Share price
-10.20%
Change (1 day)
-68.13%
Change (1 year)

Earnings for Spero Therapeutics (SPRO)

Earnings in 2026 (TTM): NZ$10.99 Million

According to Spero Therapeutics's latest financial reports the company's current earnings are NZ$42.96 Million. In 2025 the company made an earning of NZ$13.08 Million, an increase over its 2024 earnings that were of -NZ$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spero Therapeutics from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$10.99 M-15.98%
2025 NZ$13.08 M-109.88%
2024 -NZ$0.14 Billion-360.42%
2023 NZ$50.87 M-163.53%
2022 -NZ$80.09 Million-50.14%
2021 -NZ$0.17 Billion11.06%
2020 -NZ$0.15 Billion25.15%
2019 -NZ$0.12 Billion47.68%
2018 -NZ$78.25 Million5.61%
2017 -NZ$74.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
IBM
IBM
NZ$19.20 B 158,792.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Thomson Reuters
TRI
NZ$3.61 B 29,800.18%๐Ÿ‡จ๐Ÿ‡ฆ Canada
Franklin Covey
FC
NZ$11.74 M-2.80%๐Ÿ‡บ๐Ÿ‡ธ USA